Biomarkers and basic science research • 2024 MDS Congress

Prof. Brit Mollenhauer, Chair of the Movement Disorders Hospital in Germany, dives into the world of biomarker research and its impact on neurodegenerative diseases. She emphasizes the importance of collaboration between clinicians and basic scientists, arguing that MDS's diversity can enhance innovation. The discussion touches on how environmental factors and climate change relate to these diseases. Mollenhauer also explores the multifunctional role of alpha-synuclein, revealing its intriguing potential beyond just neurodegeneration.